These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 8366661)

  • 1. High density lipoprotein and low density lipoprotein attenuate the inhibitory effects of oxidized low density lipoprotein on endothelium-dependent arterial relaxation.
    Matsuda Y
    Kobe J Med Sci; 1993 Feb; 39(1):1-14. PubMed ID: 8366661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High density lipoprotein reverses inhibitory effect of oxidized low density lipoprotein on endothelium-dependent arterial relaxation.
    Matsuda Y; Hirata K; Inoue N; Suematsu M; Kawashima S; Akita H; Yokoyama M
    Circ Res; 1993 May; 72(5):1103-9. PubMed ID: 8477522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidized low-density lipoprotein inhibits acetylcholine-induced vasorelaxation and increases 5-HT-induced vasoconstriction in isolated human saphenous vein.
    Zhao L; Tackett RL
    J Pharmacol Exp Ther; 1998 Feb; 284(2):637-43. PubMed ID: 9454809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins.
    Kugiyama K; Kerns SA; Morrisett JD; Roberts R; Henry PD
    Nature; 1990 Mar; 344(6262):160-2. PubMed ID: 2106627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporin and oxidized low density lipoproteins synergistically potentiate vasoconstriction: influence of the endothelium.
    Galle J; Schollmeyer P; Wanner C
    Eur Heart J; 1993 Nov; 14 Suppl I():111-7. PubMed ID: 8293762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipids and progression of renal disease: role of modified low density lipoprotein and lipoprotein(a).
    Wanner C; Greiber S; Krämer-Guth A; Heinloth A; Galle J
    Kidney Int Suppl; 1997 Dec; 63():S102-6. PubMed ID: 9407434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective enhancement of 5-hydroxytryptamine-induced contraction of porcine coronary artery by oxidized low-density lipoprotein.
    Cox DA; Cohen ML
    J Pharmacol Exp Ther; 1996 Mar; 276(3):1095-103. PubMed ID: 8786540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-specific inhibition by human lipoproteins of endothelium dependent relaxation in rat aorta may be attributed to lipoprotein phospholipids.
    Lewis TV; Dart AM; Chin-Dusting JP
    Cardiovasc Res; 1997 Jun; 34(3):590-6. PubMed ID: 9231043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of endothelial cell protein C activation by native and oxidized low density lipoprotein.
    Wilson BD; Pitas RE; Rodgers GM
    Semin Thromb Hemost; 1992 Jan; 18(1):11-7. PubMed ID: 1574712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms underlying the chronic pravastatin treatment-induced improvement in the impaired endothelium-dependent aortic relaxation seen in streptozotocin-induced diabetic rats.
    Kobayashi T; Matsumoto T; Kamata K
    Br J Pharmacol; 2000 Sep; 131(2):231-8. PubMed ID: 10991915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of oxidized low density lipoprotein on nitric oxide synthetase and protein kinase C activities in bovine endothelial cells.
    Mukherjee S; Coaxum SD; Maleque M; Das SK
    Cell Mol Biol (Noisy-le-grand); 2001 Sep; 47(6):1051-8. PubMed ID: 11785656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of 17 beta-estradiol on endothelial function injured by oxidized low-density lipoproteins.
    Peng CF; Li YJ; Deng HW; Xiong XM
    Zhongguo Yao Li Xue Bao; 1996 May; 17(3):252-5. PubMed ID: 9812750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular incorporation of alpha-tocopherol prevents endothelial dysfunction due to oxidized LDL by inhibiting protein kinase C stimulation.
    Keaney JF; Guo Y; Cunningham D; Shwaery GT; Xu A; Vita JA
    J Clin Invest; 1996 Jul; 98(2):386-94. PubMed ID: 8755649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Native and oxidized low-density lipoproteins modulate the vasoactive actions of soluble beta-amyloid peptides in rat aorta.
    Smith CC; Stanyer L; Betteridge DJ; Cooper MB
    Clin Sci (Lond); 2007 Dec; 113(11):427-34. PubMed ID: 17531005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LPC in oxidized LDL elicits vasocontraction and inhibits endothelium- dependent relaxation.
    Murohara T; Kugiyama K; Ohgushi M; Sugiyama S; Ohta Y; Yasue H
    Am J Physiol; 1994 Dec; 267(6 Pt 2):H2441-9. PubMed ID: 7810742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impairment of endothelium-dependent aorta relaxation by phospholipid components of oxidized low-density lipoprotein.
    Vasques E; Almeida AL; Noya V; D'Alegria B; Marathe G; McIntyre TM; Tibiriçá E; Bozza PT; Silva AR; Castro-Faria-Neto HC
    Endothelium; 2006; 13(1):1-8. PubMed ID: 16885061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative contribution of individual oxidized components in ox-LDL to inhibition on endothelium-dependent relaxation in rat aorta.
    Wong WT; Ng CH; Tsang SY; Huang Y; Chen ZY
    Nutr Metab Cardiovasc Dis; 2011 Mar; 21(3):157-64. PubMed ID: 20005687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative modification of low-density lipoproteins and the inhibition of relaxations mediated by endothelium-derived nitric oxide in rabbit aorta.
    Plane F; Bruckdorfer KR; Kerr P; Steuer A; Jacobs M
    Br J Pharmacol; 1992 Jan; 105(1):216-22. PubMed ID: 1596684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deleterious effect of glycation on the ability of HDL to counteract the inhibitory effect of oxidized LDL on endothelium-dependent vasorelaxation.
    Brindisi MC; Duvillard L; Monier S; Vergès B; Perségol L
    Diabetes Metab Res Rev; 2013 Nov; 29(8):618-23. PubMed ID: 23908137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidized lipoprotein(a) inhibits endothelium-dependent dilation: prevention by high density lipoprotein.
    Galle J; Bengen J; Schollmeyer P; Wanner C
    Eur J Pharmacol; 1994 Nov; 265(1-2):111-5. PubMed ID: 7883023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.